Filing Details
- Accession Number:
- 0001415889-24-030316
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-31 16:15:13
- Reporting Period:
- 2024-12-27
- Accepted Time:
- 2024-12-31 16:15:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1817229 | Vor Biopharma Inc. | VOR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1789076 | C. Eyal Attar | C/O Vor Biopharma Inc. 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-27 | 10,334 | $1.25 | 81,439 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024.
Billionaire Hedge Funds
